Marrone Bio Innovations (MBII) Rating Lowered to Strong Sell at ValuEngine
ValuEngine lowered shares of Marrone Bio Innovations (NASDAQ:MBII) from a sell rating to a strong sell rating in a report published on Thursday morning.
Other equities research analysts also recently issued reports about the company. HC Wainwright set a $4.00 price target on Marrone Bio Innovations and gave the stock a buy rating in a report on Thursday, December 21st. Zacks Investment Research downgraded Marrone Bio Innovations from a hold rating to a sell rating in a report on Thursday, February 15th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of $2.50.
Shares of Marrone Bio Innovations (NASDAQ:MBII) traded up $0.07 during midday trading on Thursday, hitting $1.18. The company had a trading volume of 92,749 shares, compared to its average volume of 72,316. The company has a debt-to-equity ratio of -1.14, a current ratio of 0.69 and a quick ratio of 0.36. Marrone Bio Innovations has a 52-week low of $0.85 and a 52-week high of $2.30.
WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.watchlistnews.com/marrone-bio-innovations-mbii-rating-lowered-to-strong-sell-at-valuengine/1907133.html.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.